| Literature DB >> 33675956 |
Alice Marino1, Derek J Hausenloy2, Ioanna Andreadou3, Sandrine Horman1, Luc Bertrand1, Christophe Beauloye4.
Abstract
Heart failure is one of the leading causes of death and disability worldwide. Left ventricle remodeling, fibrosis, and ischemia/reperfusion injury all contribute to the deterioration of cardiac function and predispose to the onset of heart failure. Adenosine monophosphate-activated protein kinase (AMPK) is the universally recognized energy sensor which responds to low ATP levels and restores cellular metabolism. AMPK activation controls numerous cellular processes and, in the heart, it plays a pivotal role in preventing onset and progression of disease. Excessive reactive oxygen species (ROS) generation, known as oxidative stress, can activate AMPK, conferring an additional role of AMPK as a redox-sensor. In this review, we discuss recent insights into the crosstalk between ROS and AMPK. We describe the molecular mechanisms by which ROS activate AMPK and how AMPK signaling can further prevent heart failure progression. Ultimately, we review the potential therapeutic approaches to target AMPK for the treatment of cardiovascular disease and prevention of heart failure.Entities:
Keywords: AMPK; Cardiac hypertrophy; HFpEF; HFrEF; Heart failure; Ischemia; Ischemia/reperfusion injury; Nox; ROS; Reperfusion
Mesh:
Substances:
Year: 2021 PMID: 33675956 DOI: 10.1016/j.freeradbiomed.2021.02.047
Source DB: PubMed Journal: Free Radic Biol Med ISSN: 0891-5849 Impact factor: 7.376